Literature DB >> 17478727

Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.

Jawahar L Mehta1, Nobuhito Sanada, Chang Ping Hu, Jiawei Chen, Abhijit Dandapat, Fumiaki Sugawara, Hiroo Satoh, Kazuhiko Inoue, Yosuke Kawase, Kou-ichi Jishage, Hiroshi Suzuki, Motohiro Takeya, Laura Schnackenberg, Richard Beger, Paul L Hermonat, Maria Thomas, Tatsuya Sawamura.   

Abstract

Atherosclerosis is associated with oxidative stress and inflammation, and upregulation of LOX-1, an endothelial receptor for oxidized LDL (oxLDL). Here, we describe generation of LOX-1 knockout (KO) mice in which binding of oxLDL to aortic endothelium was reduced and endothelium-dependent vasorelaxation preserved after treatment with oxLDL (P<0.01 versus wild-type mice). To address whether endothelial functional preservation might lead to reduction in atherogenesis, we crossed LOX-1 KO mice with LDLR KO mice and fed these mice 4% cholesterol/10% cocoa butter diet for 18 weeks. Atherosclerosis was found to cover 61+/-2% of aorta in the LDLR KO mice, but only 36+/-3% of aorta in the double KO mice. Luminal obstruction and intima thickness were significantly reduced in the double KO mice (versus LDLR KO mice). Expression of redox-sensitive NF-kappaB and the inflammatory marker CD68 in LDLR KO mice was increased (P<0.01 versus wild-type mice), but not in the double KO mice. On the other hand, antiinflammatory cytokine IL-10 expression and superoxide dismutase activity were low in the LDLR KO mice (P<0.01 versus wild-type mice), but not in the double KO mice. Endothelial nitric oxide synthase expression was also preserved in the double KO mice. The proinflammatory signal MAPK P38 was activated in the LDLR KO mice, and LOX-1 deletion reduced this signal. In conclusion, LOX-1 deletion sustains endothelial function leading to a reduction in atherogenesis in association with reduction in proinflammatory and prooxidant signals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478727     DOI: 10.1161/CIRCRESAHA.107.149724

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  151 in total

1.  LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse.

Authors:  J Lu; X Wang; W Wang; H Muniyappa; C Hu; S Mitra; B Long; K Das; J L Mehta
Journal:  Gene Ther       Date:  2011-09-22       Impact factor: 5.250

2.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

Review 3.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

4.  Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.

Authors:  Dayuan Li; Amit R Patel; Alexander L Klibanov; Christopher M Kramer; Mirta Ruiz; Bum-Yong Kang; Jawahar L Mehta; George A Beller; David K Glover; Craig H Meyer
Journal:  Circ Cardiovasc Imaging       Date:  2010-05-04       Impact factor: 7.792

5.  Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.

Authors:  Jens De Vos; Iris Mathijs; Catarina Xavier; Sam Massa; Ulrich Wernery; Luc Bouwens; Tony Lahoutte; Serge Muyldermans; Nick Devoogdt
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

6.  Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and relapsing-fever Borrelia.

Authors:  Alvaro Toledo; Javier D Monzón; James L Coleman; Juan C Garcia-Monco; Jorge L Benach
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

7.  Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.

Authors:  Tanu Goyal; Sona Mitra; Magomed Khaidakov; Xianwei Wang; Sandeep Singla; Zufeng Ding; Shijie Liu; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2012-01-29       Impact factor: 5.113

8.  LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis.

Authors:  Zufeng Ding; Shijie Liu; Xianwei Wang; Yao Dai; Magomed Khaidakov; Xiaoyan Deng; Yubo Fan; David Xiang; Jawahar L Mehta
Journal:  Cardiovasc Res       Date:  2014-04-28       Impact factor: 10.787

9.  Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes.

Authors:  Carrie J Finno; Matthew H Bordbari; Stephanie J Valberg; David Lee; Josi Herron; Kelly Hines; Tamer Monsour; Erica Scott; Danika L Bannasch; James Mickelson; Libin Xu
Journal:  Free Radic Biol Med       Date:  2016-10-15       Impact factor: 7.376

10.  Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

Authors:  Yujun Cai; Jian-Dong Li; Chen Yan
Journal:  Biochem Biophys Res Commun       Date:  2013-04-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.